Cincinnati Clinical Research Site (Site #2401)

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• HIV2 trials
• Hepatitis B1 trial

Phase

• Phase 22 trials

Status

• Completed1 trial
• Not yet recruiting1 trial

Lead sponsor

• National Institute of Allergy and Infectious Diseases (NIAID)2 trials

Running trials

• Not yet recruiting

  A Clinical Study of Ixazomib to Reactivate HIV and Reduce HIV Reservoir Size

  NCT07881809· Phase 2· National Institute of Allergy and Infectious Diseases (NIAID)· Source

  Contact: Carl Fichtenbaum

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• HIV1 recruiting

Closed trials

• Completed

  Study of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B and HIV

  NCT05551273· Phase 2· National Institute of Allergy and Infectious Diseases (NIAID)· Source